SOURCE: BioMedReports


May 12, 2011 08:03 ET

Report: Shortage of Radioisotopes Threatens Medical Research and Treatment

LOS ANGELES, CA--(Marketwire - May 12, 2011) - Much of nuclear medicine depends on a steady supply of an isotope called molybdenum-99. More than 16 million nuclear imaging procedures are performed every year in the US alone, but the supply of Mo-99 and other radioisotopes has been unreliable and is in great need. In response to this ongoing crisis, strategies are being formulated to increase radioisotope production in the US. Some of the best new strategies are in play at Kennewick, WA-based Advanced Medical Isotope Corporation (OTCBB: ADMD).

Advanced Medical Isotope Corporation hopes to commercialize a proprietary Mo-99 production method initially conceived by University of Missouri researchers. The method involves a squat, meter-long vessel containing heavy water (deuterium oxide) and uranium.

A special report about Advanced Medical Isotope Corporation and their answer to this crisis is now available at:

In addition, investors interested in accessing BioMedReports' new complete database of clinical trials and upcoming FDA and world-wide regulatory decisions can go to:

News developments and live healthcare sector updates are available constantly via twitter at:

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets.

Full disclosures and information about the stocks are available at BioMedReports.Com

Contact Information

  • Media Contacts Only:
    Mary Davila
    Assistant Editor
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556